Inhibition of PI3K pathway increases immune infiltrate in muscle-invasive bladder cancer

Inhibition of PI3K pathway increases immune infiltrate in muscle-invasive bladder cancer

Although immune checkpoint inhibitors have shown improvement in survival in comparison to chemotherapy in urothelial bladder cancer, many patients still fail to respond to these treatments and actual efforts are made to identify predictive factors of response to immunotherapy. Understanding the tumo...

Full description

Bibliographic Details
Main Authors: Edith Borcoman, Philippe De La Rochere, Wilfrid Richer, Sophie Vacher, Walid Chemlali, Clémentine Krucker, Nanour Sirab, Francois Radvanyi, Yves Allory, Géraldine Pignot, Nicolas Barry de Longchamps, Diane Damotte, Didier Meseure, Christine Sedlik, Ivan Bieche, Eliane Piaggio
Format: Article
Language:English
Published: Taylor & Francis Group 2019-05-01
Series:OncoImmunology
Subjects:
bladder cancer
pik3ca mutation
targeted therapy
immunotherapy
Online Access:http://dx.doi.org/10.1080/2162402X.2019.1581556

Internet

http://dx.doi.org/10.1080/2162402X.2019.1581556

Similar Items